These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3619427)

  • 41. [Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases].
    Urabe A; Takaku F; Kitagawa S; Miura Y; Dan K; Nomura T; Masuda M; Mizoguchi H; Yano T; Toyama K
    Jpn J Antibiot; 1987 Apr; 40(4):749-58. PubMed ID: 3613092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH; Eggleston M
    Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical experience with Timentin in severe hospital infections.
    Meylan PR; Calandra T; Casey PA; Glauser MP
    J Antimicrob Chemother; 1986 May; 17 Suppl C():127-39. PubMed ID: 3636328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical evaluation of a ticarcillin-clavulanic acid combination in severe infections in adults].
    Lacut JY; Quentin C; Cardoso-Mendes I; Dupon M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):591-5. PubMed ID: 3937132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
    File TM; Tan JS; Salstrom SJ; Johnson LA; Douglas GF
    Antimicrob Agents Chemother; 1984 Sep; 26(3):310-3. PubMed ID: 6508263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of the combination of Timentin and tobramycin in the treatment of patients with bacteraemia.
    Degener JE; Wagenvoort JH; Dzoljic-Danilovic G; Michel MF; Brus-Weijer A
    J Antimicrob Chemother; 1986 May; 17 Suppl C():141-8. PubMed ID: 3636329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An open study of Timentin for the initial treatment of serious infections.
    Davey PG; Main J; Scott AC
    J Antimicrob Chemother; 1986 May; 17 Suppl C():161-8. PubMed ID: 3636331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid.
    Bennett S; Wise R; Weston D; Dent J
    Antimicrob Agents Chemother; 1983 Jun; 23(6):831-4. PubMed ID: 6614890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum levels and pharmacokinetics of ticarcillin and clavulanic acid in dog following parenteral administration of Timentin.
    Garg RC; Keefe TJ; Vig MM
    J Vet Pharmacol Ther; 1987 Dec; 10(4):324-30. PubMed ID: 3501810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacology and safety evaluation of Timentin.
    Jackson D; Cockburn A; Cooper DL; Langley PF; Tasker TC; White DJ
    Am J Med; 1985 Nov; 79(5B):44-55. PubMed ID: 4073095
    [No Abstract]   [Full Text] [Related]  

  • 51. Timentin therapy for Staphylococcus aureus infections in children: results of a multicenter trial.
    Jacobs RF; Elser JM
    Pediatr Infect Dis J; 1989 Jul; 8(7):441-4. PubMed ID: 2666942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
    Meunier F; Snoeck R; Lagast H; Woussen F; Klastersky J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():195-201. PubMed ID: 3636334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
    Mackie MJ; Reilly JT; Purohit S; Bartzokas CA
    J Antimicrob Chemother; 1986 May; 17 Suppl C():219-24. PubMed ID: 3522529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of ticarcillin disodium/potassium clavulanate.
    Tasker TC; Cockburn A; Jackson D; Mellows G; White D
    J Antimicrob Chemother; 1986 May; 17 Suppl C():225-32. PubMed ID: 3722044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical pharmacology of timentin (ticarcillin and clavulanic acid).
    Bodey GP; Yeo E; Ho DH; Rolston K; LeBlanc B
    Clin Pharmacol Ther; 1985 Aug; 38(2):134-9. PubMed ID: 4017415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Penetration to peripheral human lymph of clavulanic acid and ticarcillin.
    Bergan T; Olszewski W; Engeset A
    J Antimicrob Chemother; 1986 Jan; 17(1):97-103. PubMed ID: 3949640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR; Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic experience with ticarcillin disodium plus potassium clavulanate in the Federal Republic of Germany--results of a multicentre-study.
    Heilmann HD
    Int J Clin Pharmacol Res; 1987; 7(3):233-7. PubMed ID: 3596864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Timentin in the antimicrobial treatment of nosocomial and polymicrobial infections.
    Carlet J; Goldstein FW; Blériot JP; Bahloul F; Dazza FE
    J Antimicrob Chemother; 1986 May; 17 Suppl C():149-59. PubMed ID: 3636330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid.
    Roselle GA; Bode R; Hamilton B; Bibler M; Sullivan R; Douce R; Staneck JL; Bullock WE
    Antimicrob Agents Chemother; 1985 Mar; 27(3):291-6. PubMed ID: 3888101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.